继续使用褪黑素来对抗SARS-CoV-2的δ变体的理由

Melatonin Research Pub Date : 2021-09-30 DOI:10.32794/mr112500107

R. Reiter, D. Cardinali, R. L. Neel, Alberto Domínguez Rodríguez, Gregory M. Brown, J. Tesarik

{"title":"继续使用褪黑素来对抗SARS-CoV-2的δ变体的理由","authors":"R. Reiter, D. Cardinali, R. L. Neel, Alberto Domínguez Rodríguez, Gregory M. Brown, J. Tesarik","doi":"10.32794/mr112500107","DOIUrl":null,"url":null,"abstract":"Melatonin was shown to prevent or mitigate a number of different respiratory and non-respiratory viral diseases. Given its non-specific anti-viral action, it is likely to be effective against the delta variant of SARS-CoV-2 as well as any eventual future variants of the virus.","PeriodicalId":18604,"journal":{"name":"Melatonin Research","volume":"29 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2021-09-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2\",\"authors\":\"R. Reiter, D. Cardinali, R. L. Neel, Alberto Domínguez Rodríguez, Gregory M. Brown, J. Tesarik\",\"doi\":\"10.32794/mr112500107\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Melatonin was shown to prevent or mitigate a number of different respiratory and non-respiratory viral diseases. Given its non-specific anti-viral action, it is likely to be effective against the delta variant of SARS-CoV-2 as well as any eventual future variants of the virus.\",\"PeriodicalId\":18604,\"journal\":{\"name\":\"Melatonin Research\",\"volume\":\"29 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2021-09-30\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Melatonin Research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.32794/mr112500107\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Melatonin Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.32794/mr112500107","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 2

摘要

褪黑素被证明可以预防或减轻许多不同的呼吸道和非呼吸道病毒疾病。鉴于其非特异性抗病毒作用，它可能对SARS-CoV-2的δ型变体以及该病毒的任何最终未来变体有效。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

查看原文本刊更多论文

Rationale for the continued use of melatonin to combat the delta variant of SARS-CoV-2

Melatonin was shown to prevent or mitigate a number of different respiratory and non-respiratory viral diseases. Given its non-specific anti-viral action, it is likely to be effective against the delta variant of SARS-CoV-2 as well as any eventual future variants of the virus.

求助全文

通过发布文献求助，成功后即可免费获取论文全文。去求助

来源期刊

Melatonin Research

自引率

0.00%

发文量